General MedicationsINTRAVENOUSStandard
FLUORODOPA F18
FLUORODOPA F-18
Standard Dose
1-40mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview FLUORODOPA F18 is listed in Drugs@FDA under application 200655 (NDA).
Review priority: N/A Marketing status: Prescription Active ingredient FLUORODOPA F-18 Form and strength SOLUTION;INTRAVENOUS - 1-40mCi/ML Sponsor FEINSTEIN Submission history Latest submission status date: 2020-12-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview FLUORODOPA F18 is listed in Drugs@FDA under application 200655 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient FLUORODOPA F-18 Form and strength SOLUTION;INTRAVENOUS - 1-40mCi/ML Sponsor FEINSTEIN Submission history Latest submission status date: 2020-12-11 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.